Diagnosis and treatment of pregnancy associated breast cancer

Abstract

ZHANG Shuo, WANG Meng-Sen, YU Yong-Hua. Diagnosis and treatment of pregnancy associated breast cancer[J]. Journal of International Oncology, 2013, 40(11): 853-857.

［1］ Sophie E, McGrath, Alistair R. Chemotherapy for breast cancer in pregnancy: evidence and guidance for oncologists. Ther Adv Med Oncol, 2011, 3(2)：73-83. ［2］ Polyak K. Pregnancy and breast cancer: the other side of the coin. Cancer Cell, 2006, 9 (3)：151-153. ［3］李俊杰, 邵志敏. 妊娠期乳腺癌的诊治进展. 中国癌症杂志, 2007, 17(10)：824-827. ［4］ Navrozoglou I, Vrekoussis T, Kontostolis E, et al. Breast cancer during pregnancy: a minireview. Eur J Surg Oncol, 2008,34(8)：837-843. ［5］ Molckovsky A, Madarnas Y. Breast cancer in pregnancy: a literature review. Breast Cancer Res Treat， 2008，108(3)：333-338. ［6］李元仙, 项尖尖. 超声诊断妊娠哺乳期乳腺癌的价值. 中国妇幼保健, 2010, 25：1993-1994. ［7］姜军, 范林军. 妊娠哺乳期乳腺癌的几个临床问题. 中国实用妇科与产科杂志, 2008, 24(11)： 813-815. ［8］朱丽英. 妊娠哺乳期乳腺癌37例临床分析. 实用肿瘤学杂志, 2007, 21(5)：443-444. ［9］ Cardonick E, Gilmandyar D, Somer RA. Maternal and neonatal outcomes of dose-dense chemotherapy for breast cancer in pregnancy. Obstet Gynecol, 2012, 120(6)：1267-1272. ［10］牛占恩, 袁堂玲, 李霞, 等. 妊娠哺乳期乳腺癌6例临床分析并文献回顾. 现代肿瘤医学, 2008, 16(8)：1323-1326. ［11］ Gemignani ML. Breast cancer screening: why, when, and how many?. Clin Obstet Gynecol, 2011, 54(1)：125-132. ［12］ Azim HA Jr, Peccatori FA. Treatment of metastatic breast cancer during pregnancy: we need to talk!. Breast, 2008, 17(4)：426-428. ［13］ Gentilini O, Botteri E, Veronesi P, et al. Repeating conservative surgery after ipsilateral breast tumor reappearance: criteria for selecting the best candidates. Ann Surg Oncol, 2012 , 19(12)：3771-3776. ［14］ Azim HA Jr, Botteri E, Renne G, et al. The biological features and prognosis of breast cancer diagnosed during pregnancy: a casecontrol study. Acta Oncol, 2012, 51(5)：653-661. ［15］ Mondi MM, Cuenca RE, Ollila DW, et al. Sentinel lymph node biopsy during pregnancy: initial clinical experience. Ann Surg Oncol, 2007,14(1)：218-221. ［16］ Morris PG, King F, Kennedy MJ. Cytotoxic chemotherapy for pregnancyassociated breast cancer: single institution case series. J Oncol Pharm Pract, 2009, 15(4)：241-247. ［17］ Mir O, Berveiller P, Ropert S, et al. Emerging therapeutic options for breast cancer chemotherapy during pregnancy. Ann Oncol, 2008, 19(4):607-613. ［18］ Loibl S, Han SN, von Minckwitz G. Treatment of breast cancer during pregnancy: an observational study. Lancet Oncol, 2012,13(9)：887-896. ［19］ Cardonick E, Dougherty R, Grana G. Breast cancer during pregnancy: maternal and fetal outcomes. Cancer, 2010,16 (1)：76-82. ［20］ Skrablin S, Banovic V, Matkovic V. Adriamycin and cyclophosphamide chemotherapy in advanced breast cancer in pregnancy. Eur J Obstet Gynecol Reprod Biol, 2007,33(2)：251-252. ［21］ Mathelin C, Treisser A, Chenard MP, et al. Pregnancy and postpartum breast cancer: a prospective study. Anticancer Res, 2008, 28(4C):2447-2452. ［22］ Amant F, Deckers S, Van Calsteren K, et al. Breast cancer in pregnancy: recommendations of an international consensus meeting. Eur J Cancer, 2010, 46(18)：3158-3168. ［23］ Rajaraman P, Simpson J, Neta G, et al. Early life exposure to diagnostic radiation and ultrasound scans and risk of childhood cancer: casecontrol study. BMJ, 2011, 342:d472. ［24］余艳红, 周俊, 龚时鹏. 妊娠合并乳腺癌的诊治. 实用妇产科杂志, 2007, 23(9)：526-528. ［25］ Leal SC, Stuart SR, Carvalho Hde A. Breast irradiation and lactation: a review. Expert Rev Anticancer Ther， 2013,13(2)：159-164. ［26］ Luis SA, Christie DR, Kaminski A, et al. Pregnancy and radiotherapy: management options for minimising risk, case series and comprehensive literature review. J Med Imaging Radiat Oncol, 2009,53(6)：559-568. ［27］ Ives A, Saunders C, Bulsara M. Pregnancy after breast cancer: population based study. BMJ, 2007,334(7586):194.

[1]	Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou.Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer[J]. Journal of International Oncology, 2024, 51(6): 321-325.
[2]	Qian Xiaotao, Shi Ziyi, Hu Ge, Wu Xiaowei.Efficacy of consolidation chemotherapy after radical radiotherapy and chemotherapy for stage Ⅲ-ⅣA esophageal squamous cell carcinoma： a real-world clinical study[J]. Journal of International Oncology, 2024, 51(6): 326-331.
[3]	Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun.Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer[J]. Journal of International Oncology, 2024, 51(6): 332-337.
[4]	Yuan Jian, Huang Yanhua.Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer[J]. Journal of International Oncology, 2024, 51(6): 338-343.
[5]	Zhang Baihong, Yue Hongyun.Advances in anti-tumor drugs with new mechanisms of action[J]. Journal of International Oncology, 2024, 51(6): 354-358.
[6]	Xu Fenglin, Wu Gang.Research progress of EBV in tumor immune microenvironment and immunotherapy of nasopharyngeal carcinoma[J]. Journal of International Oncology, 2024, 51(6): 359-363.
[7]	Wang Ying, Liu Nan, Guo Bing.Advances of antibody-drug conjugate in the therapy of metastatic breast cancer[J]. Journal of International Oncology, 2024, 51(6): 364-369.
[8]	Gao Fan, Wang Ping, Du Chao, Chu Yanliu.Research progress on intestinal flora and non-surgical treatment of the colorectal cancer[J]. Journal of International Oncology, 2024, 51(6): 376-381.
[9]	Fan Zhipeng, Yu Jing, Hu Jing, Liao Zhengkai, Xu Yu, Ouyang Wen, Xie Conghua.Predictive value of changes in inflammatory markers for prognosis in patients with advanced non-small cell lung cancer treated with the first-line immunotherapy plus chemotherapy[J]. Journal of International Oncology, 2024, 51(5): 257-266.
[10]	Zhang Ningning, Yang Zhe, Tan Limei, Li Zhenning, Wang Di, Wei Yongzhi.Diagnostic value of cervical cell DNA ploidy analysis combined with B7-H4 and PKCδ for cervical cancer[J]. Journal of International Oncology, 2024, 51(5): 286-291.
[11]	Chen Qi, Xu Chenyang, Wang Yin, Lei Dapeng.Current application status of hyperspectral imaging in the diagnosis and treatment of head and neck tumor[J]. Journal of International Oncology, 2024, 51(5): 298-302.
[12]	Wang Peixin, Zhao Jun, Xu Shihong, Jiang Zhaoyang, Wang Xiaoqiang, Yang Hongjuan.Progress of ferroptosis-related mechanisms in osteosarcoma[J]. Journal of International Oncology, 2024, 51(5): 308-311.
[13]	Yang Hao, Shi Guidong, Zhang Chengcheng, Zhang Yue, Zhang Liwen, Fu Maoyong.Comparison of efficacy and safety between sintilimab and tislelizumab in neoadjuvant therapy for advanced esophageal squamous cell carcinoma[J]. Journal of International Oncology, 2024, 51(4): 210-216.
[14]	Sa Qiang, Xu Hangcheng, Wang Jiayu.Advances in immunotherapy for breast cancer[J]. Journal of International Oncology, 2024, 51(4): 227-234.
[15]	Yang Zhi, Lu Yiqiao, Gu Huayan, Ding Jialing, Guo Guilong.Research progress of tumor microenvironment mediated drug resistance in targeted therapy of breast cancer[J]. Journal of International Oncology, 2024, 51(4): 235-238.

Diagnosis and treatment of pregnancy associated breast cancer

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles15

Recommended Articles

Metrics

Comments